Consistent with previously conducted studies, this study also demonstrated that exposure to alisertib contributed to cancer cells harboring relative resistance to it, in association with the aberrant expression of STAT1 mRNA and protein levels (Figure 1). The gene discussed is STAT1; the disease is cancer.